|
UBFD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66710000248926E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11589999463035E-08 |
| Normal-vs-Stage2 |
1.418980E-03 |
| Normal-vs-Stage3 |
5.636100E-04 |
| Normal-vs-Stage4 |
3.97340000000135E-05 |
| Stage1-vs-Stage2 |
6.026400E-01 |
| Stage1-vs-Stage3 |
9.270300E-02 |
| Stage1-vs-Stage4 |
9.498800E-01 |
| Stage2-vs-Stage3 |
5.026000E-01 |
| Stage2-vs-Stage4 |
6.236800E-01 |
| Stage3-vs-Stage4 |
1.927610E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89250000115493E-08 |
| Normal-vs-AfricanAmerican |
4.2056000000068E-05 |
| Normal-vs-Asian |
1.591510E-04 |
| Caucasian-vs-AfricanAmerican |
5.657600E-01 |
| Caucasian-vs-Asian |
9.921800E-01 |
| AfricanAmerican-vs-Asian |
5.898600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.32639999999673E-05 |
| Normal-vs-Female |
1.41970000200331E-08 |
| Male-vs-Female |
4.941200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.10040000445011E-08 |
| Normal-vs-Age(41-60Yrs) |
4.58080000043104E-07 |
| Normal-vs-Age(61-80Yrs) |
1.581310E-03 |
| Normal-vs-Age(81-100Yrs) |
1.045450E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.025400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.780200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.385000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.966010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.198200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.771800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.260600E-01 |
| Classical-VS-Follicular |
5.63190000000269E-05 |
| Classical-VS-Other |
3.064400E-01 |
| Classical-VS-Normal |
9.17039777448281E-11 |
| Tall-VS-Follicular |
1.969610E-01 |
| Tall-VS-Other |
6.954600E-01 |
| Tall-VS-Normal |
1.758450E-03 |
| Follicular-VS-Other |
7.522800E-01 |
| Follicular-VS-Normal |
5.623800E-02 |
| Other-VS-Normal |
3.652400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78408000000019E-05 |
| Normal-vs-N1 |
1.144090E-02 |
| N0-vs-N1 |
6.971200E-01 |
|
|
